免疫系统
免疫学
医学
败血症
免疫抑制
先天免疫系统
免疫
细胞毒性T细胞
免疫耐受
淋巴细胞
生物
生物化学
体外
作者
Jinghua Gao,Zheying Liu,Zhifeng Liu
出处
期刊:PubMed
日期:2020-01-01
卷期号:32 (1): 121-125
被引量:2
标识
DOI:10.3760/cma.j.cn121430-20190916-00023
摘要
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. The pathophysiology core issue is that the body initiates a severe inflammatory reaction in response to the invasion of pathogenic microorganisms at the initial stage of disease. Subsequently, the body begins to fight inflammation in order to balance immunity status and eventually induces the immune paralysis or immunosuppressive state characterized by exhaustion of immune cell. Both in innate immunity and in acquired immunity, some co-suppressor molecules on the surface of immune cells play important roles in immunosuppression, such as, programmed death receptor-1 (PD-1), T cell immunoglobulin and mucin-containing protein-3 (TIM-3), cytotoxic T lymphocyte associated antigen-4 (CTLA-4), natural killer cell receptor 2B4 (CD244), B and T lymphocyte attenuator (BTLA) and NKG2A (CD94), et al. Blocking the interaction between these co-suppressor molecules and their ligands can significantly reverse the immunosuppressive state in septic animal models or patients. In order to provide a reference for the monitoring and treatment of sepsis immune dysfunction, this article mainly summarizes the new findings on the role of those co-suppressor molecules in sepsis immune dysfunction in recent years.
科研通智能强力驱动
Strongly Powered by AbleSci AI